Page last updated: 2024-12-07

nicotone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nicotone: conversion product of nicotine N-oxide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID85906
SCHEMBL ID20897347
MeSH IDM0143982

Synonyms (17)

Synonym
2-methyl-6-(3-pyridinyl)-1,2-oxazinane
nicotone
15769-88-7
2-methyl-6-(3-pyridyl)tetrahydro-1,2-oxazine
2-methyl-6-pyridin-3-yloxazinane
AKOS006278625
2h-1,2-oxazine, tetrahydro-2-methyl-6-(3-pyridinyl)-, (-)-
unii-1rey93u6jz
1rey93u6jz ,
2-methyl-6-(3-pyridinyl)-1,2-oxazinane #
2h-1,2-oxazine, tetrahydro-2-methyl-6-(3-pyridyl)-
RSFSUBQOZSKHFU-UHFFFAOYSA-N
tetrahydro-2-methyl-6-(3-pyridinyl)-2h-1,2-oxazine
2h-1,2-oxazine, tetrahydro-2-methyl-6-(3-pyridinyl)-
2-methyl-6-(pyridin-3-yl)-1,2-oxazinane
DTXSID10935778
SCHEMBL20897347
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 104.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index104.39 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index184.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (104.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]